The molecule represents a significant step in the evolution of incretin-pathway tools, extending the dual-agonist concept of Tirzepatide with an added glucagon component intended to engage hepatic and thermogenic pathways
Like any medication, they carry potential side effects and aren't right for everyone
Salehi M, Aulinger BA, DAlessio DA
Shin EJ, Nah SY, Chae JS, Bing G, Shin SW, Yen TP, et al
Within dietary supplements, its share remains under 1%, while in functional foods and beverages, it accounts for less than 0.5%
For accuracy, discuss dilution options with your veterinarian